GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ben Tre Pharmaceutical JSC (STC:DBT) » Definitions » Cash-to-Debt

Ben Tre Pharmaceutical JSC (STC:DBT) Cash-to-Debt : 0.00 (As of . 20)


View and export this data going back to 2020. Start your Free Trial

What is Ben Tre Pharmaceutical JSC Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Ben Tre Pharmaceutical JSC's cash to debt ratio for the quarter that ended in . 20 was 0.00.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Ben Tre Pharmaceutical JSC couldn't pay off its debt using the cash in hand for the quarter that ended in . 20.

The historical rank and industry rank for Ben Tre Pharmaceutical JSC's Cash-to-Debt or its related term are showing as below:

STC:DBT's Cash-to-Debt is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.92
* Ranked among companies with meaningful Cash-to-Debt only.

Ben Tre Pharmaceutical JSC Cash-to-Debt Historical Data

The historical data trend for Ben Tre Pharmaceutical JSC's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Ben Tre Pharmaceutical JSC Cash-to-Debt Chart

Ben Tre Pharmaceutical JSC Annual Data
Trend
Cash-to-Debt

Ben Tre Pharmaceutical JSC Semi-Annual Data
Cash-to-Debt

Competitive Comparison of Ben Tre Pharmaceutical JSC's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, Ben Tre Pharmaceutical JSC's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ben Tre Pharmaceutical JSC's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ben Tre Pharmaceutical JSC's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Ben Tre Pharmaceutical JSC's Cash-to-Debt falls into.



Ben Tre Pharmaceutical JSC Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Ben Tre Pharmaceutical JSC's Cash to Debt Ratio for the fiscal year that ended in . 20 is calculated as:

Do not have enough data to calculate Cash to Debt ratio.

Ben Tre Pharmaceutical JSC's Cash to Debt Ratio for the quarter that ended in . 20 is calculated as:

Do not have enough data to calculate Cash to Debt ratio.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ben Tre Pharmaceutical JSC  (STC:DBT) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


Ben Tre Pharmaceutical JSC Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Ben Tre Pharmaceutical JSC's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Ben Tre Pharmaceutical JSC (STC:DBT) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
6A3, 60 National Highway, Phu Tan Ward, Ben Tre Town, Ben Tre, VNM
Ben Tre Pharmaceutical JSC is engaged in producing and trading of medicine. It also imports medicine, package, materials additives, and flavoring for production. It manufactures and distributes medicament and health equipment in Ho Chi Minh, Hanoi, Danang, and Can Tho.

Ben Tre Pharmaceutical JSC (STC:DBT) Headlines

No Headlines